Observational study revealed dapagliflozin improves albuminuria in patients with diabetic nephropathy, indicating potential benefits for renal health.
This prospective observational study aimed to analyze the clinical efficacy of dapagliflozin in the treatment of diabetic nephropathy and its impact on albuminuria levels.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: